Press coverage about The Ensign Group (NASDAQ:ENSG) has trended somewhat positive this week, according to Accern Sentiment. The research firm identifies negative and positive news coverage by analyzing more than twenty million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. The Ensign Group earned a news sentiment score of 0.18 on Accern’s scale. Accern also gave news stories about the company an impact score of 46.0864548003175 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.
Here are some of the media headlines that may have effected Accern’s rankings:
- The Ensign Group, Inc. (ENSG) Expected to Post Quarterly Sales of $490.17 Million (americanbankingnews.com)
- The Ensign Group to Present at the Oppenheimer 28th Annual Healthcare Conference (finance.yahoo.com)
- Zacks: Analysts Anticipate The Ensign Group, Inc. (ENSG) Will Post Earnings of $0.45 Per Share (americanbankingnews.com)
- Why Is The Ensign Group (ENSG) Up 16.8% Since Its Last Earnings Report? (finance.yahoo.com)
- The Ensign Group (ENSG) Upgraded at BidaskClub (americanbankingnews.com)
ENSG has been the topic of a number of research analyst reports. Stifel Nicolaus set a $22.00 target price on The Ensign Group and gave the company a “hold” rating in a report on Friday, February 9th. BidaskClub lowered The Ensign Group from a “buy” rating to a “hold” rating in a report on Tuesday, December 5th. SunTrust Banks set a $29.00 target price on The Ensign Group and gave the company a “buy” rating in a report on Friday, February 9th. Zacks Investment Research raised The Ensign Group from a “hold” rating to a “buy” rating and set a $29.00 target price on the stock in a report on Friday, February 16th. Finally, Royal Bank of Canada reaffirmed a “buy” rating on shares of The Ensign Group in a report on Monday, February 12th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the company. The company currently has a consensus rating of “Buy” and an average price target of $26.80.
The Ensign Group (NASDAQ:ENSG) last released its earnings results on Thursday, February 8th. The company reported $0.40 earnings per share (EPS) for the quarter, meeting the Zacks’ consensus estimate of $0.40. The firm had revenue of $487.70 million for the quarter, compared to analyst estimates of $457.91 million. The Ensign Group had a return on equity of 13.87% and a net margin of 2.19%. The company’s revenue was up 12.6% on a year-over-year basis. During the same quarter last year, the firm posted $0.30 EPS. equities research analysts forecast that The Ensign Group will post 1.69 earnings per share for the current fiscal year.
In other The Ensign Group news, Director John G. Nackel sold 7,000 shares of the firm’s stock in a transaction that occurred on Tuesday, February 27th. The stock was sold at an average price of $27.90, for a total value of $195,300.00. Following the completion of the sale, the director now owns 84,232 shares in the company, valued at approximately $2,350,072.80. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director John G. Nackel sold 2,000 shares of the firm’s stock in a transaction that occurred on Friday, February 9th. The stock was sold at an average price of $24.90, for a total value of $49,800.00. Following the completion of the sale, the director now owns 99,232 shares of the company’s stock, valued at approximately $2,470,876.80. The disclosure for this sale can be found here. Insiders sold a total of 117,310 shares of company stock valued at $2,930,044 in the last quarter. Corporate insiders own 6.20% of the company’s stock.
The Ensign Group Company Profile
The Ensign Group, Inc, through its operating subsidiaries, provides healthcare services across the post-acute care continuum, as well as other ancillary businesses located in Arizona, California, Colorado, Idaho, Iowa, Kansas, Nebraska, Nevada, Oregon, South Carolina, Texas, Utah, Washington and Wisconsin.
Receive News & Ratings for The Ensign Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Ensign Group and related companies with MarketBeat.com's FREE daily email newsletter.